Diffuse Glioma clinical trials

Explore recruiting diffuse glioma clinical trials.

Recruiting diffuse glioma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diffuse Glioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)

Netherlands, Germany, Italy, Spain, Denmark, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma

Netherlands, Norway

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Diffuse Glioma trials by city

Diffuse Glioma in Toronto Diffuse Glioma in Vancouver Diffuse Glioma in Montreal Diffuse Glioma in Calgary Diffuse Glioma in Edmonton Diffuse Glioma in Ottawa Diffuse Glioma in Winnipeg Diffuse Glioma in Quebec City Diffuse Glioma in Hamilton Diffuse Glioma in Kitchener Diffuse Glioma in London Diffuse Glioma in Halifax Diffuse Glioma in New York Diffuse Glioma in Los Angeles Diffuse Glioma in Chicago Diffuse Glioma in Houston

Diffuse Glioma clinical trials

Recruiting diffuse glioma studies right now

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

GD2-CAR T Cells for Pediatric Brain Tumours

CAR T Cells to Target GD2 for DMG

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Also recruiting in Europe

ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)

The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma

Diffuse Glioma trials by city

Other conditions